MIAMI, FL / ACCESSWIRE / March 24, 2016 / EmergingGrowth.com - Graphene 3D Lab (OTCQB: GPHBF) wholly owned subsidiary Graphene Laboratories, Inc. offers over 100 Graphene and related products to more than 10,000 customers worldwide including every Fortune 500 tech company and major research university.
GPHBF seems to be vastly overlooked by the financial community. The company is in the business of developing, manufacturing, and marketing proprietary graphene-based nanocomposite materials for various types of 3D printing and most recently announced a functional magnetic filament to its product line which will allow 3D printing of projects with components that attracted to magnetic fields.
The company's go-to-market product, Conductive Graphene Filament, brings users the ability to 3D print circuitry and sensors for electronic applications and future plans include the development of a multi-tool 3D printer which can open the door for 3D printing functional and electronic devices in a no hassle one-button process.
GPHBF currently has six US Patent applications pending for its technology.
It is difficult to identify an industry with better prospects for a tremendous ROI than 3D printing.
According to Goldman Sachs (NYSE: GS), 3D printing is one of eight technologies notable as a "creative destroyer" - it will force manufacturing companies to adapt or become obsolete, while simultaneously opening new technological avenues as a highly disruptive technology.
In 2016, Hewlett-Packard (NYSE: HPQ) will look to increase its market share in its 3D Printer segment. According to a report from A.T. Kearney, the 3D printer market is expected to grow at a CAGR (compound annual growth rate) of 25% from $4.5 billion in 2014 to $17 billion in 2020. Hewlett-Packard believes that the 3D printing space will be disruptive as well as profitable in the next few years.
Once over $2.00 per share, the stock has been beaten down into the teens. GPHBF stock has been on a steady rise in the recent days, and with their already existent customer base, the stock could begin to see new levels.
We reported on Net Element, Inc. (NASDAQ: NETE) back in December when the stock was approximately .20 per share. At that time, the company announced 171% increase in subscribers to over 3 million over the 2015 calendar year.
Since, we have seen NETE pop almost 100% to .40 per share in just over three short months. Warren Buffett once said that he decides if he is going to invest in a company or not by seeing how many cars are in the parking lot. If the parking lot is full, he invests. Today, the same metrics can be geared to subscribers and customers.
Elite Pharmaceuticals, Inc. (OTCQB: ELTP) was reported on back in February at approximately .30 per share. Since, the company announced that the New Drug Application (NDA) for SequestOXTM(ELI-200), Elite's lead opioid abuse-deterrent candidate for the management of moderate to severe pain where the use of an opioid analgesic is appropriate, has been accepted and granted priority review by the United States Food and Drug Administration ("FDA"). The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016.
The stock traded up 13% just five short weeks from our reference on over $2 million traded on March 17.
When we reported on Cliffs Natural Resources (NYSE: CLF) back in February, of the eight analysts covering CLF, 8 give it a hold and 7, a sell, focusing on negative revenue growth year over year.
Since then, we saw CLF rise 100% from $1.70 to $3.40 per share in less than 20 trading sessions.
ABOUT EmergingGrowth.com:
We focus on Emerging Growth companies that can be overlooked by the investment community. The smaller companies that make the large ones great have potentially more room to grow than the large companies themselves. We look for innovation, strategy, and execution. We specialize in growth oriented and acquisition minded companies both publically traded and privately held. If you have an idea for an "Emerging Growth" company, drop us a line at EmergingGrowth1@gmail.com.
DISCLOSURE:
All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. EmergingGrowth.com may either hold stock in or have been compensated by or for a company or companies mentioned in this article. EmergingGrowth.com does not have a position in any securities mentioned in this article. Please view our full disclosure which can be found here, http://www.emerginggrowth.com/disclosure-47423/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.
CONTACT:
Company: EmergingGrowth.com - http://www.EmergingGrowth.com
Contact Email: EmergingGrowth1@gmail.com
SOURCE: EmergingGrowth.com
